NuTech NuCel: A Prospective, Efficacy Study of NuCel in Patients Undergoing Fusion for One, Two or Three Level Degenerative Disease of the Lumbar Spine
Phase of Trial: Phase II
Latest Information Update: 20 May 2019
Price : $35 *
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Intervertebral disc degeneration
- Focus Therapeutic Use
- Sponsors Nutech Medical
- 15 May 2019 Planned End Date changed from 1 Aug 2020 to 1 Jun 2020.
- 15 May 2019 Planned primary completion date changed from 1 Nov 2019 to 1 Jun 2020.
- 20 Feb 2019 Status changed from active, no longer recruiting to recruiting.